| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 32 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 3 | OXALIPLATIN | 24 |
| 4 | PREDNISONE | 24 |
| 5 | ETOPOSIDE | 23 |
| 6 | DEXAMETHASONE | 22 |
| 7 | DEXAMETHASONE 1.5 MG | 22 |
| 8 | NIVOLUMAB | 22 |
| 9 | CARBOPLATIN | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOSTARLIMAB | 13 | 0.0052 |
| 1 | CARBIDOPA LEVODOPA | 6 | 0.0017 |
| 2 | NITROUS OXIDE | 3 | 0.0014 |
| 3 | APREPITANT | 10 | 0.0013 |
| 4 | DACARBAZINE | 10 | 0.0013 |
| 5 | BRENTUXIMAB VEDOTIN | 13 | 0.0012 |
| 6 | MESNA INJECTION | 10 | 0.0012 |
| 7 | MESNA | 10 | 0.0012 |
| 8 | ADAGRASIB | 1 | 0.0009 |
| 9 | TRAMETINIB | 14 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 13 | 0.0012 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 3 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 5 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 50 | 0.0005 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Topoisomerase Inhibitor [EPC] | 23 | 0.0003 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |